Eli Lilly CEO says middle-income consumers driving 'largest new category expansion' in pharma

Eli Lilly CEO David Ricks said demand for weight-loss medicines is extending beyond very-high-net-worth consumers, with middle-income households increasingly interested in losing weight at scale. Shares closed at a record Thursday.

Detected & updated continuously · Source: Nebula